Meta-analysis identifies common gut microbiota associated with multiple sclerosis.
Faecalibacterium
Prevotella
Meta-analysis
Microbiota
Multiple sclerosis
Journal
Genome medicine
ISSN: 1756-994X
Titre abrégé: Genome Med
Pays: England
ID NLM: 101475844
Informations de publication
Date de publication:
31 Jul 2024
31 Jul 2024
Historique:
received:
16
06
2023
accepted:
12
07
2024
medline:
1
8
2024
pubmed:
1
8
2024
entrez:
31
7
2024
Statut:
epublish
Résumé
Previous studies have identified a diverse group of microbial taxa that differ between patients with multiple sclerosis (MS) and the healthy population. However, interpreting findings on MS-associated microbiota is challenging, as there is no true consensus. It is unclear whether there is gut microbiota commonly altered in MS across studies. To answer this, we performed a meta-analysis based on the 16S rRNA gene sequencing data from seven geographically and technically diverse studies comprising a total of 524 adult subjects (257 MS and 267 healthy controls). Analysis was conducted for each individual study after reprocessing the data and also by combining all data together. The blocked Wilcoxon rank-sum test and linear mixed-effects regression were used to identify differences in microbial composition and diversity between MS and healthy controls. Network analysis was conducted to identify bacterial correlations. A leave-one-out sensitivity analysis was performed to ensure the robustness of the findings. The microbiome community structure was significantly different between studies. Re-analysis of data from individual studies revealed a lower relative abundance of Prevotella in MS across studies, compared to controls. Meta-analysis found that although alpha and beta diversity did not differ between MS and controls, a higher abundance of Actinomyces and a lower abundance of Faecalibacterium were reproducibly associated with MS. Additionally, network analysis revealed that the recognized negative Bacteroides-Prevotella correlation in controls was disrupted in patients with MS. Our meta-analysis identified common gut microbiota associated with MS across geographically and technically diverse studies.
Sections du résumé
BACKGROUND
BACKGROUND
Previous studies have identified a diverse group of microbial taxa that differ between patients with multiple sclerosis (MS) and the healthy population. However, interpreting findings on MS-associated microbiota is challenging, as there is no true consensus. It is unclear whether there is gut microbiota commonly altered in MS across studies.
METHODS
METHODS
To answer this, we performed a meta-analysis based on the 16S rRNA gene sequencing data from seven geographically and technically diverse studies comprising a total of 524 adult subjects (257 MS and 267 healthy controls). Analysis was conducted for each individual study after reprocessing the data and also by combining all data together. The blocked Wilcoxon rank-sum test and linear mixed-effects regression were used to identify differences in microbial composition and diversity between MS and healthy controls. Network analysis was conducted to identify bacterial correlations. A leave-one-out sensitivity analysis was performed to ensure the robustness of the findings.
RESULTS
RESULTS
The microbiome community structure was significantly different between studies. Re-analysis of data from individual studies revealed a lower relative abundance of Prevotella in MS across studies, compared to controls. Meta-analysis found that although alpha and beta diversity did not differ between MS and controls, a higher abundance of Actinomyces and a lower abundance of Faecalibacterium were reproducibly associated with MS. Additionally, network analysis revealed that the recognized negative Bacteroides-Prevotella correlation in controls was disrupted in patients with MS.
CONCLUSIONS
CONCLUSIONS
Our meta-analysis identified common gut microbiota associated with MS across geographically and technically diverse studies.
Identifiants
pubmed: 39085949
doi: 10.1186/s13073-024-01364-x
pii: 10.1186/s13073-024-01364-x
doi:
Substances chimiques
RNA, Ribosomal, 16S
0
Types de publication
Journal Article
Meta-Analysis
Langues
eng
Sous-ensembles de citation
IM
Pagination
94Subventions
Organisme : NIH HHS
ID : R01 NS102633
Pays : United States
Informations de copyright
© 2024. The Author(s).
Références
Mirza A, Forbes JD, Zhu F, Bernstein CN, Van Domselaar G, Graham M, Waubant E, Tremlett H. The multiple sclerosis gut microbiota: a systematic review. Mult Scler Relat Disord. 2020;37:101427.
pubmed: 32172998
doi: 10.1016/j.msard.2019.101427
Cantoni C, Lin Q, Dorsett Y, Ghezzi L, Liu Z, Pan Y, Chen K, Han Y, Li Z, Xiao H, et al. Alterations of host-gut microbiome interactions in multiple sclerosis. EBioMedicine. 2022;76:103798.
pubmed: 35094961
pmcid: 8814376
doi: 10.1016/j.ebiom.2021.103798
Katz Sand I, Zhu Y, Ntranos A, Clemente JC, Cekanaviciute E, Brandstadter R, Crabtree-Hartman E, Singh S, Bencosme Y, Debelius J, et al. Disease-modifying therapies alter gut microbial composition in MS. Neurol Neuroimmunol Neuroinflamm. 2019;6:e517.
pubmed: 30568995
doi: 10.1212/NXI.0000000000000517
Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S, Nelson CA, Kanner R, Bencosme Y, Lee YK, Hauser SL, et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci U S A. 2017;114:10713–8.
pubmed: 28893978
pmcid: 5635915
doi: 10.1073/pnas.1711235114
Chen J, Chia N, Kalari KR, Yao JZ, Novotna M, Paz Soldan MM, Luckey DH, Marietta EV, Jeraldo PR, Chen X, et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep. 2016;6:28484.
pubmed: 27346372
pmcid: 4921909
doi: 10.1038/srep28484
Choileain SN, Kleinewietfeld M, Raddassi K, Hafler DA, Ruff WE, Longbrake EE. CXCR3+ T cells in multiple sclerosis correlate with reduced diversity of the gut microbiome. J Transl Autoimmun. 2020;3:100032.
pubmed: 32743517
doi: 10.1016/j.jtauto.2019.100032
Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R, Patel B, Mazzola MA, Liu S, Glanz BL, et al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 2016;7:12015.
pubmed: 27352007
pmcid: 4931233
doi: 10.1038/ncomms12015
Miyake S, Kim S, Suda W, Oshima K, Nakamura M, Matsuoka T, Chihara N, Tomita A, Sato W, Kim SW, et al. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters. PLoS One. 2015;10:e0137429.
pubmed: 26367776
pmcid: 4569432
doi: 10.1371/journal.pone.0137429
Tremlett H, Zhu F, Arnold D, Bar-Or A, Bernstein CN, Bonner C, Forbes JD, Graham M, Hart J, Knox NC, et al. The gut microbiota in pediatric multiple sclerosis and demyelinating syndromes. Ann Clin Transl Neurol. 2021;8:2252–69.
pubmed: 34889081
pmcid: 8670321
doi: 10.1002/acn3.51476
Tremlett H, Fadrosh DW, Faruqi AA, Zhu F, Hart J, Roalstad S, Graves J, Lynch S, Waubant E. Centers USNoPM: Gut microbiota in early pediatric multiple sclerosis: a case-control study. Eur J Neurol. 2016;23:1308–21.
pubmed: 27176462
doi: 10.1111/ene.13026
Zeng Q, Junli G, Liu X, Chen C, Sun X, Li H, Zhou Y, Cui C, Wang Y, Yang Y, et al. Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis. Neurochem Int. 2019;129:104468.
pubmed: 31108132
doi: 10.1016/j.neuint.2019.104468
Berer K, Gerdes LA, Cekanaviciute E, Jia X, Xiao L, Xia Z, Liu C, Klotz L, Stauffer U, Baranzini SE, et al. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc Natl Acad Sci U S A. 2017;114:10719–24.
pubmed: 28893994
pmcid: 5635914
doi: 10.1073/pnas.1711233114
Swidsinski A, Dorffel Y, Loening-Baucke V, Gille C, Goktas O, Reisshauer A, Neuhaus J, Weylandt KH, Guschin A, Bock M. Reduced mass and diversity of the colonic microbiome in patients with multiple sclerosis and their improvement with ketogenic diet. Front Microbiol. 2017;8:1141.
pubmed: 28702003
pmcid: 5488402
doi: 10.3389/fmicb.2017.01141
Reynders T, Devolder L, Valles-Colomer M, Van Remoortel A, Joossens M, De Keyser J, Nagels G, D’Hooghe M, Raes J. Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes. Ann Clin Transl Neurol. 2020;7:406–19.
pubmed: 32162850
pmcid: 7187717
doi: 10.1002/acn3.51004
Forbes JD, Chen CY, Knox NC, Marrie RA, El-Gabalawy H, de Kievit T, Alfa M, Bernstein CN, Van Domselaar G. A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist? Microbiome. 2018;6:221.
pubmed: 30545401
pmcid: 6292067
doi: 10.1186/s40168-018-0603-4
Tankou SK, Regev K, Healy BC, Tjon E, Laghi L, Cox LM, Kivisakk P, Pierre IV, Hrishikesh L, Gandhi R, et al. A probiotic modulates the microbiome and immunity in multiple sclerosis. Ann Neurol. 2018;83:1147–61.
pubmed: 29679417
pmcid: 6181139
doi: 10.1002/ana.25244
Kozhieva M, Naumova N, Alikina T, Boyko A, Vlassov V, Kabilov MR. Primary progressive multiple sclerosis in a Russian cohort: relationship with gut bacterial diversity. BMC Microbiol. 2019;19:309.
pubmed: 31888483
pmcid: 6937728
doi: 10.1186/s12866-019-1685-2
Teng F, Darveekaran Nair SS, Zhu P, Li S, Huang S, Li X, Xu J, Yang F. Impact of DNA extraction method and targeted 16S-rRNA hypervariable region on oral microbiota profiling. Sci Rep. 2018;8:16321.
pubmed: 30397210
pmcid: 6218491
doi: 10.1038/s41598-018-34294-x
Duvallet C, Gibbons SM, Gurry T, Irizarry RA, Alm EJ. Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nat Commun. 2017;8:1784.
pubmed: 29209090
pmcid: 5716994
doi: 10.1038/s41467-017-01973-8
Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581–3.
pubmed: 27214047
pmcid: 4927377
doi: 10.1038/nmeth.3869
Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114–20.
pubmed: 24695404
pmcid: 4103590
doi: 10.1093/bioinformatics/btu170
Rognes T, Flouri T, Nichols B, Quince C, Mahe F. VSEARCH: a versatile open source tool for metagenomics. PeerJ. 2016;4:e2584.
pubmed: 27781170
pmcid: 5075697
doi: 10.7717/peerj.2584
Nearing JT, Douglas GM, Hayes MG, MacDonald J, Desai DK, Allward N, Jones CMA, Wright RJ, Dhanani AS, Comeau AM, Langille MGI. Microbiome differential abundance methods produce different results across 38 datasets. Nat Commun. 2022;13:342.
pubmed: 35039521
pmcid: 8763921
doi: 10.1038/s41467-022-28034-z
Li Y, Ge X, Peng F, Li W, Li JJ. Exaggerated false positives by popular differential expression methods when analyzing human population samples. Genome Biol. 2022;23:79.
pubmed: 35292087
pmcid: 8922736
doi: 10.1186/s13059-022-02648-4
Shah S, Locca A, Dorsett Y, Cantoni C, Ghezzi L, Lin Q, Bokoliya S, Panier H, Suther C, Gormley M, et al. Alterations of the gut mycobiome in patients with MS. EBioMedicine. 2021;71:103557.
pubmed: 34455391
pmcid: 8399064
doi: 10.1016/j.ebiom.2021.103557
Wirbel J, Pyl PT, Kartal E, Zych K, Kashani A, Milanese A, Fleck JS, Voigt AY, Palleja A, Ponnudurai R, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med. 2019;25:679–89.
pubmed: 30936547
pmcid: 7984229
doi: 10.1038/s41591-019-0406-6
Sheu CF, Suzuki S. Meta-analysis using linear mixed models. Behav Res Methods Instrum Comput. 2001;33:102–7.
pubmed: 11447661
doi: 10.3758/BF03195354
Pasolli E, Truong DT, Malik F, Waldron L, Segata N. Machine learning meta-analysis of large metagenomic datasets: tools and biological insights. PLoS Comput Biol. 2016;12:e1004977.
pubmed: 27400279
pmcid: 4939962
doi: 10.1371/journal.pcbi.1004977
Faust K, Sathirapongsasuti JF, Izard J, Segata N, Gevers D, Raes J, Huttenhower C. Microbial co-occurrence relationships in the human microbiome. PLoS Comput Biol. 2012;8:e1002606.
pubmed: 22807668
pmcid: 3395616
doi: 10.1371/journal.pcbi.1002606
Friedman J, Alm EJ. Inferring correlation networks from genomic survey data. PLoS Comput Biol. 2012;8:e1002687.
pubmed: 23028285
pmcid: 3447976
doi: 10.1371/journal.pcbi.1002687
Riviere A, Selak M, Lantin D, Leroy F, De Vuyst L. Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol. 2016;7:979.
pubmed: 27446020
pmcid: 4923077
doi: 10.3389/fmicb.2016.00979
Gorvitovskaia A, Holmes SP, Huse SM. Interpreting Prevotella and Bacteroides as biomarkers of diet and lifestyle. Microbiome. 2016;4:15.
pubmed: 27068581
pmcid: 4828855
doi: 10.1186/s40168-016-0160-7
Roager HM, Licht TR, Poulsen SK, Larsen TM, Bahl MI. Microbial enterotypes, inferred by the prevotella-to-bacteroides ratio, remained stable during a 6-month randomized controlled diet intervention with the new nordic diet. Appl Environ Microbiol. 2014;80:1142–9.
pubmed: 24296500
pmcid: 3911217
doi: 10.1128/AEM.03549-13
Zhou X, Baumann R, Gao X, Mendoza M, Singh S, Katz Sand I, Xia Z, et al. Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course. Cell. 2022;185(19):3467-86.
Zhou Y, Mihindukulasuriya KA, Gao H, La Rosa PS, Wylie KM, Martin JC, Kota K, Shannon WD, Mitreva M, Sodergren E, Weinstock GM. Exploration of bacterial community classes in major human habitats. Genome Biol. 2014;15:R66.
pubmed: 24887286
pmcid: 4073010
doi: 10.1186/gb-2014-15-5-r66
Shahi SK, Freedman SN, Murra AC, Zarei K, Sompallae R, Gibson-Corley KN, Karandikar NJ, Murray JA, Mangalam AK. Prevotella histicola, a human gut commensal, is as potent as COPAXONE(R) in an animal model of multiple sclerosis. Front Immunol. 2019;10:462.
pubmed: 30984162
pmcid: 6448018
doi: 10.3389/fimmu.2019.00462
Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, et al. Enterotypes of the human gut microbiome. Nature. 2011;473:174–80.
pubmed: 21508958
pmcid: 3728647
doi: 10.1038/nature09944
Manor O, Dai CL, Kornilov SA, Smith B, Price ND, Lovejoy JC, Gibbons SM, Magis AT. Health and disease markers correlate with gut microbiome composition across thousands of people. Nat Commun. 2020;11:5206.
pubmed: 33060586
pmcid: 7562722
doi: 10.1038/s41467-020-18871-1
Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes J, Corthier G, Marteau P, Dore J. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15:1183–9.
pubmed: 19235886
doi: 10.1002/ibd.20903
Ueda A, Shinkai S, Shiroma H, Taniguchi Y, Tsuchida S, Kariya T, Kawahara T, Kobayashi Y, Kohda N, Ushida K, et al. Identification of Faecalibacterium prausnitzii strains for gut microbiome-based intervention in Alzheimer’s-type dementia. Cell Rep Med. 2021;2:100398.
pubmed: 34622235
pmcid: 8484692
doi: 10.1016/j.xcrm.2021.100398
Stopinska K, Radziwon-Zaleska M, Domitrz I. The microbiota-gut-brain axis as a key to neuropsychiatric disorders: a mini review. J Clin Med. 2021;10(20):4640.
pubmed: 34682763
pmcid: 8539144
doi: 10.3390/jcm10204640
Cosorich I, Dalla-Costa G, Sorini C, Ferrarese R, Messina MJ, Dolpady J, Radice E, Mariani A, Testoni PA, Canducci F, et al. High frequency of intestinal T(H)17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Sci Adv. 2017;3:e1700492.
pubmed: 28706993
pmcid: 5507635
doi: 10.1126/sciadv.1700492
Chirouze C, Patry I, Duval X, Baty V, Tattevin P, Aparicio T, Pagenault M, Carbonnel F, Couetdic G, Hoen B. Streptococcus bovis/Streptococcus equinus complex fecal carriage, colorectal carcinoma, and infective endocarditis: a new appraisal of a complex connection. Eur J Clin Microbiol Infect Dis. 2013;32:1171–6.
pubmed: 23558362
doi: 10.1007/s10096-013-1863-3
Teitelbaum JE, Triantafyllopoulou M. Inflammatory bowel disease and Streptococcus bovis. Dig Dis Sci. 2006;51:1439–42.
pubmed: 16868828
doi: 10.1007/s10620-005-9053-5
Topkaya AE, Sahin S, Aksungar FB, Boru UT, Yildiz Z, Sur H. Is there any relationship between streptococcal infection and multiple sclerosis? Med Sci Monit. 2007;13:CR567-569.
pubmed: 18049437
Herrmann I, Kellert M, Schmidt H, Mildner A, Hanisch UK, Bruck W, Prinz M, Nau R. Streptococcus pneumoniae infection aggravates experimental autoimmune encephalomyelitis via Toll-like receptor 2. Infect Immun. 2006;74:4841–8.
pubmed: 16861672
pmcid: 1539614
doi: 10.1128/IAI.00026-06
Kitamoto S, Nagao-Kitamoto H, Jiao Y, Gillilland MG 3rd, Hayashi A, Imai J, Sugihara K, Miyoshi M, Brazil JC, Kuffa P, et al. The intermucosal connection between the mouth and gut in commensal pathobiont-driven colitis. Cell. 2020;182(447–462):e414.
Lin Q, Dorsett Y, Mirza A, Tremlett H, Piccio L, Longbrake EE, Ni Choileain S, Hafler DA, Cox LM, Weiner HL, Yamamura T, Chen K, Wu Y, Zhou Y. Meta-analysis for MS. GitHub. https://github.com/YZhouLabUConnHealth/meta_analysis_MS (2024).